Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia

Clinical trial NCT04609865 · TERMINATED

Trial details

NCT number: NCT04609865
Sponsor: University Hospital, Strasbourg, France
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome (ARDS)COVID-19 Corona Virus Infection

Start date: 2020-11-04
Primary completion: 2022-03-17
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.